{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T13:44:30Z","timestamp":1780407870181,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.clon.2004.11.014","type":"journal-article","created":{"date-parts":[[2005,4,10]],"date-time":"2005-04-10T07:08:30Z","timestamp":1113116910000},"page":"271-276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Glutamine as a Neuroprotective Agent in High-dose Paclitaxel-induced Peripheral Neuropathy: A Clinical and Electrophysiologic Study"],"prefix":"10.1016","volume":"17","author":[{"given":"M.D.","family":"Stubblefield","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.T.","family":"Vahdat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.M.","family":"Balmaceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Troxel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Hesdorffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.L.","family":"Gooch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2004.11.014_bib1","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1081\/CNV-120018236","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"21","author":"Visovsky","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clon.2004.11.014_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/PL00007853","article-title":"Chemotherapy-induced peripheral neuropathy","volume":"249","author":"Quasthoff","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.clon.2004.11.014_bib3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0149-2918(03)90011-7","article-title":"Gabapentin dosing for neuropathic pain: evidence from randomized, placebo-controlled clinical trials","volume":"25","author":"Miroslav","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clon.2004.11.014_bib4","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1212\/WNL.50.6.1842","article-title":"A double-blind, randomized trial of tramadol for treatment of the pain of diabetic neuropathy","volume":"50","author":"Harati","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.clon.2004.11.014_bib5","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0304-3959(99)00154-2","article-title":"Efficacy of pharmacological treatments of neuropathic pain: an update and effect related mechanism of drug action","volume":"83","author":"Sindrup","year":"1999","journal-title":"Pain"},{"key":"10.1016\/j.clon.2004.11.014_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/sj.bmt.1703592","article-title":"Phase II trial of sequential high-dose chemotherapy with paclitaxel, melphalan and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer","volume":"30","author":"Vahdat","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clon.2004.11.014_bib7","first-page":"29","article-title":"Analysis of response to weekly 1h taxol plus herceptin by immunophenotypic analysis in HER-2 overexpressing and nonoverexpressing metastatic breast cancer","volume":"57","author":"Esteva","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clon.2004.11.014_bib8","first-page":"85a","article-title":"Final report: weekly herceptin and taxol for metastatic breast cancer; analysis of efficacy by HER-2 immunophenotype and gene amplification","volume":"19","author":"Seidman","year":"2000","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib9","first-page":"1","article-title":"Clinical toxicities encountered with paclitaxel (taxol)","volume":"20","author":"Rowinsky","year":"1993","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib10","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1023\/A:1008380800394","article-title":"Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel","volume":"10","author":"Lee","year":"1999","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/gyno.1998.5226","article-title":"Use of low-dose oral prednisone to prevent paclitaxel-induced arthralgias and myalgias","volume":"72","author":"Markman","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib12","first-page":"3038","article-title":"Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer","volume":"17","author":"Gelmon","year":"1999","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib13","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.1200\/JCO.1998.16.12.3918","article-title":"Glutamine treatment of paclitaxel-induced myalgias and arthralgias","volume":"16","author":"Savarese","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1097\/00000658-199805000-00018","article-title":"Effect of glutamine on methotrexate efficacy and toxicity","volume":"227","author":"Rubio","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/j.clon.2004.11.014_bib15","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1177\/0148607195019006492","article-title":"Effect of glutamine supplementation on protein metabolism and glutathione in tumor-bearing rats","volume":"19","author":"Yoshida","year":"1995","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.clon.2004.11.014_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0024-3205(88)90627-3","article-title":"Reduction of tumor growth following treatments with a glutamine antimetabolite","volume":"42","author":"Chance","year":"1988","journal-title":"Life Sci"},{"key":"10.1016\/j.clon.2004.11.014_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF02303705","article-title":"Effect of glutamine on tumor and host growth","volume":"2","author":"Bartlett","year":"1995","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clon.2004.11.014_bib18","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0002-9610(96)00217-6","article-title":"Glutamine, cancer, and its therapy","volume":"172","author":"Kinberg","year":"1996","journal-title":"Am J Surg"},{"key":"10.1016\/j.clon.2004.11.014_bib19","doi-asserted-by":"crossref","first-page":"94S","DOI":"10.1177\/014860719001400412","article-title":"Glutamine nutrition and requirements","volume":"14","author":"Smith","year":"1990","journal-title":"J Parenter Enteral Nutr"},{"key":"10.1016\/j.clon.2004.11.014_bib20","first-page":"1689","article-title":"Phase I trial of sequential high dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer","volume":"4","author":"Vahdat","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2004.11.014_bib21","first-page":"1192","article-title":"Reduction of paclitaxel-induced peripheral neuropathy with glutamine","volume":"7","author":"Vahdat","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2004.11.014_bib22","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0924-980X(97)00037-4","article-title":"The influence of active electrode placement on CMAP amplitude","volume":"105","author":"Bromberg","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.clon.2004.11.014_bib23","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/mus.880171107","article-title":"Influence of recording site on CMAP amplitude on its variation over a length of nerve","volume":"17","author":"Van Dijik","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.clon.2004.11.014_bib24","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1212\/WNL.44.8.1459","article-title":"Inter- and intraexaminer reliability of nerve conduction measurements in patients with diabetic neuropathy","volume":"44","author":"Chaudhry","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.clon.2004.11.014_bib25","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/ana.410290115","article-title":"Nerve growth factor prevents toxic neuropathy in mice","volume":"29","author":"Apfel","year":"1991","journal-title":"Ann Neurol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655505000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:24:34Z","timestamp":1760541874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655505000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0936655505000798"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2004.11.014","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glutamine as a Neuroprotective Agent in High-dose Paclitaxel-induced Peripheral Neuropathy: A Clinical and Electrophysiologic Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2004.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}